The Complexity of License Transfers
The most critical asset in any cannabis M&A transaction is the state operating license. However, state licenses are not freely transferable property. A buyer cannot simply purchase a dispensary and assume operations the next day.
Every state regulatory agency - such as the Oregon Liquor and Cannabis Commission (OLCC) or the Illinois Department of Financial and Professional Regulation (IDFPR) - requires formal approval before a change of ownership can occur. This process often mirrors the initial licensing gauntlet. The buyer must submit detailed financial disclosures, prove the source of their capitalization, and undergo rigorous criminal background checks. If the state denies the transfer application, the entire transaction collapses. Contracts must include specific contingencies detailing how the escrowed funds will be handled if regulatory approval is delayed or denied.
Regulatory Due Diligence
Due diligence in a cannabis transaction extends far beyond standard financial audits. Buyers must conduct exhaustive regulatory due diligence to ensure they are not acquiring a business burdened by compliance violations or hidden tax liabilities.
Key areas of regulatory due diligence include:
- METRC Audits: The buyer must audit the target company's seed-to-sale tracking data. Unresolved inventory discrepancies in METRC can result in massive fines or license revocation immediately after the acquisition closes.
- Municipal Zoning Verification: The buyer must verify that the facility's local conditional use permits are current and transferable. A state license is worthless if the local municipality revokes the zoning variance upon a change of ownership.
- IRC 280E Tax Exposure: Because cannabis businesses cannot deduct standard operating expenses under IRC 280E, they frequently carry massive federal tax liabilities. Buyers must scrutinize past tax returns to ensure the seller has not aggressively misclassified SG&A expenses as Cost of Goods Sold (COGS), which could trigger an IRS audit post-acquisition.
Structuring the Deal: Asset vs. Equity Purchases
Cannabis M&A transactions are typically structured as either asset purchases or equity (stock) purchases. The choice dictates how liabilities are transferred and how the transaction is taxed.
- Asset Purchases: In an asset purchase, the buyer acquires specific assets (e.g., equipment, real estate, intellectual property, and the right to apply for the license transfer) but does not acquire the seller's corporate entity. This structure is highly preferred by buyers in the cannabis industry because it leaves the seller's historical liabilities - including past regulatory infractions and pending IRS 280E audits - with the seller's original entity.
- Equity Purchases: In an equity purchase, the buyer acquires the seller's corporate stock or LLC membership interests, assuming ownership of the entire entity, including all its historical liabilities. While equity purchases can sometimes streamline the license transfer process (as the entity holding the license remains the same, merely undergoing a change of ownership), the buyer assumes massive risk regarding the seller's past compliance and tax history.
Foreign Direct Investment and Multi-State Operators (MSOs)
The expansion of Multi-State Operators (MSOs) drives significant M&A activity. However, MSOs must navigate strict tied-house rules and license caps. Many states prohibit an entity from holding licenses across multiple tiers (e.g., owning both a cultivation facility and a testing laboratory) or cap the total number of retail dispensaries a single operator can control.
Furthermore, foreign direct investment (FDI) introduces additional hurdles. Investors from Canada or Europe must ensure their capital injections do not violate state residency requirements or trigger enhanced scrutiny regarding the source of funds.